Deciphering Colorectal Cancer–Hepatocyte Interactions: A Multiomics Platform for Interrogation of Metabolic Crosstalk in the Liver–Tumor Microenvironment
Authors:
- Alisa B. NelsonANAlisa B. Nelson
- Lyndsay E. ReeseLRLyndsay E. Reese
- Elizabeth RonoERElizabeth Rono
- Eric D. QueathemEQEric D. Queathem
- Yinjie QiuYQYinjie Qiu
- Braedan M. McCluskeyBMBraedan M. McCluskey
- Alexandra CramptonACAlexandra Crampton
- Eric ConniffECEric Conniff
- Katherine CumminsKCKatherine Cummins
- Ella BoytimEBElla Boytim
- Senali DansouSDSenali Dansou
- Justin HwangJHJustin Hwang
Open Access
- 25 February 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1976
Abstract
Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to adapt to and exploit their microenvironment for sustained growth. The liver is a common site of metastasis, but the interactions between tumor cells and hepatocytes remain poorly understood. In the context of liver metastasis, these interactions play a crucial role in promoting tumor survival and progression. This study leverages multiomics coverage of the microenvironment via liquid chromatography and high-resolution, high-mass-accuracy mass spectrometry-based untargeted metabolomics, 13C-stable isotope tracing, and RNA sequencing to uncover the metabolic impact of co-localized primary hepatocytes and a colon adenocarcinoma cell line, SW480, using a 2D co-culture model. Metabolic profiling revealed disrupted Warburg metabolism with an 80% decrease in glucose consumption and 94% decrease in lactate production by hepatocyte–SW480 co-cultures relative to SW480 control cultures. Decreased glucose consumption was coupled with alterations in glutamine and ketone body metabolism, suggesting a possible fuel switch upon co-culturing. Further, integrated multiomics analysis indicates that disruptions in metabolic pathways, including nucleoside biosynthesis, amino acids, and TCA cycle, correlate with altered SW480 transcriptional profiles and highlight the importance of redox homeostasis in tumor adaptation. Finally, these findings were replicated in three-dimensional microtissue organoids. Taken together, these studies support a bioinformatic approach to study metabolic crosstalk and discovery of potential therapeutic targets in preclinical models of the tumor microenvironment.Keywords
All Related Versions
Funding Information
- University of Minnesota, Medical School Dean’s Academic Investment Research Program (AIRP) (R01DK091538, R01CA215052, T32DK007203, T32HL166142)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091538, R01CA215052, T32DK007203, T32HL166142)
- National Computational Infrastructure (R01DK091538, R01CA215052, T32DK007203, T32HL166142)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091538, R01CA215052, T32DK007203, T32HL166142)
- EDQ (R01DK091538, R01CA215052, T32DK007203, T32HL166142)
This publication has 72 references indexed in Scilit:
- Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA)Stem Cell Reviews and Reports, 2024
- Using ExpressAnalyst for Comprehensive Gene Expression Analysis in Model and Non‐Model OrganismsCurrent Protocols, 2023
- Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsCancer Cell, 2021
- Epidemiology of liver metastasesCancer Epidemiology, 2020
- Using MetaboAnalyst 4.0 for Metabolomics Data Analysis, Interpretation, and Integration with Other Omics Data2020
- Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease2019
- Expanding Lipidome Coverage Using LC-MS/MS Data-Dependent Acquisition with Automated Exclusion List GenerationJournal of the American Society for Mass Spectrometry, 2017
- Uric acid as a modulator of glucose and lipid metabolismBiochimie, 2015
- Extracellular Metabolic Energetics Can Promote Cancer ProgressionCell, 2015
- Hallmarks of Cancer: The Next GenerationCell, 2011